Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapy

Hematology

Volumn 12, Issue 5, 2007, Pages 439-440

  Junagade, P ^a   Grace, R ^a   Gover, P ^a  

^a EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; PROTHROMBIN COMPLEX; WARFARIN;

ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL ARTICLE; DRUG CHOICE; DRUG OVERDOSE; DRUG SAFETY; HEMATEMESIS; HEMOPTYSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MELENA; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; THROMBOSIS; TREATMENT RESPONSE;

ANTIDOTES; BLOOD COAGULATION FACTORS; CLINICAL AUDIT; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERNATIONAL NORMALIZED RATIO; OVERDOSE; TREATMENT OUTCOME; WARFARIN;

EID: 34748813129     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330701448529     Document Type: Article

References (4)

1. Guidelines on oral anticoagulation: Third edition. Br J Haematol, 101:2, pp. 374-387.
2. Baglin, TP, Keeling, DM, Watson, HG and The British Committee for Standards in Haematology (2006) Guidelines on oral anticoagulation (warfarin): Third edition-2005 update. Br J Haematol, 132:3, pp. 277-285.
3. Yasaka, M., Sakata, T., Naritomi, H. and Minematsu, K. (2005) Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb Res, 115:6, pp. 455-459.
4. van Aart, L., Eijkhout, HW, Kamphuis, JS, Dam, M., Schattenkerk, ME, Schouten, TJ, Ploeger, B. and Strengers, PF (2006) Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: An open, prospective randomized controlled trial. Thromb Res, 118:3, pp. 313-321.